In Vitro Activities of 21 Antimicrobial Agents Alone and in Combination with Aminoglycosides or Fluoroquinolones against Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia

被引：18
|
作者：
Cha, Min Kyeong [1 ]
Kang, Cheol-In [2 ]
Kim, So Hyun [1 ,2 ]
Cho, Sun Young [2 ]
Ha, Young Eun [2 ]
Wi, Yu Mi [3 ]
Chung, Doo Ryeon [1 ,2 ]
Peck, Kyong Ran [2 ]
Song, Jae-Hoon [1 ,2 ]
机构：
[1] APFID, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 09期
基金：
新加坡国家研究基金会;
关键词：
ANTIBIOTIC-THERAPY; MOLECULAR EPIDEMIOLOGY; SEPTIC SHOCK; RISK-FACTORS; INFECTIONS; SEPSIS; MONOTHERAPY; IMPACT;
D O I：
10.1128/AAC.01121-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro activity of various antimicrobials alone and in combination against 291 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) isolates causing bacteremia in South Korean hospitals. Ceftazidime, cefepime, and piperacillin-tazobactam in combination with amikacin showed greater activity than found in combination with ciprofloxacin. In settings with a high prevalence of ESBL-producing pathogens, combination aminoglycoside antimicrobial therapy, especially with amikacin, may be considered for empirical therapy against suspected Gram-negative sepsis as a carbapenem-saving strategy.
引用
收藏
页码：5834 / 5837
页数：4
相关论文
共 50 条
  • [41] Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: comparison of pediatric and adult populations
    Cheng, Ming-Fang
    Tsai, Wan-Ling
    Hung, Chih-Hsin
    Chen, Hui-An
    Huang, I-Fei
    Chiou, Yee-Hsuan
    Chen, Yao-Shen
    Lee, Susan Shin-Jung
    Hung, Wan-Yu
    Wang, Jiun-Ling
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S68 - S68
  • [42] Therapeutic effectiveness of hacteriophages in the rescue of mice with extended spectrum β-lactamase-producing Escherichia coli bacteremia
    Wang, J
    Hu, B
    Xu, MC
    Yan, Q
    Liu, SY
    Zhu, XH
    Sun, ZY
    Tao, DD
    Ding, L
    Reed, E
    Gong, HP
    Li, QDQ
    Hu, JB
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 347 - 355
  • [43] Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an In Vitro Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae
    Ribera, Alba
    Benavent, Eva
    El-Haj, Cristina
    Gomez-Junyent, Joan
    Tubau, Fe
    Rigo-Bonnin, Raul
    Ariza, Javier
    Murillo, Oscar
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [44] Comparison of SpectraCell RA Typing and Multilocus Sequence Typing for Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Overdevest, I. T. M. A.
    Heck, M.
    van der Zwaluw, K.
    Willemsen, I.
    van de Ven, J.
    Verhulst, C.
    Kluytmans, J. A. J. W.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (12) : 3999 - 4001
  • [45] Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages
    Fitzgerald-Hughes, Deirdre
    Bolkvadze, Darajen
    Balarjishvili, Nana
    Leshkasheli, Lika
    Ryan, Maia
    Burke, Liam
    Stevens, Niall
    Humphreys, Hilary
    Kutateladze, Mzia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1148 - 1150
  • [46] Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Song, Jae-Hoon
    Jang, Jun Ho
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4994 - 4995
  • [47] Prospective Study of Fecal Colonization by Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Neutropenic Patients with Cancer
    Calatayud, L.
    Arnan, M.
    Linares, J.
    Dominguez, M. A.
    Gudiol, C.
    Carratala, J.
    Batlle, M.
    Ribera, J. M.
    Gudiol, F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4187 - 4190
  • [48] Is Fecal Carriage of Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Urban Rats a Risk for Public Health?
    Guenther, Sebastian
    Wuttke, Julia
    Bethe, Astrid
    Vojtech, Jiri
    Schaufler, Katharina
    Semmler, Torsten
    Ulrich, Rainer G.
    Wieler, Lothar H.
    Ewers, Christa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) : 2424 - 2425
  • [49] Characteristics of the extended-spectrum-β-lactamase-producing Escherichia coli isolated from diseased livestock and poultry in Taiwan
    Kuan, Nan-Ling
    Chen, Yen-Ping
    Shien, Jui-Hung
    Yeh, Kuang-Sheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Rodriguez-Bano, Jesus
    Picon, Encarnacion
    Gijon, Paloma
    Ramon Hernandez, Jose
    Cisneros, Jose M.
    Pena, Carmen
    Almela, Manuel
    Almirante, Benito
    Grill, Fabio
    Colomina, Javier
    Molinos, Sonia
    Oliver, Antonio
    Fernandez-Mazarrasa, Carlos
    Navarro, Gemma
    Coloma, Ana
    Lopez-Cerero, Lorena
    Pascual, Alvaro
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) : 1726 - 1731
12345